- 专利标题： HYBRID MULTIVALENT INFLUENZA VACCINES COMPRISING HEMAGGLUTININ AND NEURAMINIDASE AND METHODS OF USING THE SAME
-
申请号： US18653458申请日： 2024-05-02
-
公开(公告)号： US20240285750A1公开(公告)日： 2024-08-29
- 发明人: Timothy ALEFANTIS , Mario BARRO , Saranya SRIDHAR , Thorsten VOGEL , William WARREN
- 申请人： SANOFI
- 申请人地址： FR Paris
- 专利权人： SANOFI
- 当前专利权人： SANOFI
- 当前专利权人地址： FR Paris
- 主分类号： A61K39/145
- IPC分类号： A61K39/145 ; A61K39/00 ; A61P31/16
摘要：
Disclosed herein are hybrid multivalent vaccine or immunogenic compositions comprising (i) one or more influenza virus proteins selected from one or more influenza virus hemagglutinin (HA) proteins, one or more influenza virus neuraminidase (NA) proteins, or a combination thereof; and (ii) one or more ribonucleic acid molecules encoding one or more influenza virus proteins selected from one or more influenza virus HA proteins, one or more influenza virus NA proteins, or a combination thereof. Also disclosed are methods of using the vaccine or immunogenic compositions.
信息查询
